Text Size

Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life

This study has been completed.
Sponsor:
Collaborators:
OrtoMedic A/S, Oslo
Scandinavian Customized Prosthesis (SCP)
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00638417
First received: March 12, 2008
Last updated: October 1, 2008
Last verified: October 2008
History of Changes
  Purpose

The aim of the study is to improve hospital treatment and rehabilitation of patients with hip arthroplasty to help the patients to regain functional ability in the shortest possible time, and reduce hospital and rehabilitation time to save costs for the patient and society.

Optimal reconstruction of the hip joint and the effect of an intensive physical training programme are compared to conventional rehabilitation programmes.


Condition Intervention Phase
Osteoarthritis, Hip
 Procedure: Maximal strength training
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Norwegian University of Science and Technology:

Enrollment: 24
Study Start Date: January 2006
Study Completion Date: November 2007
Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Maximal strength training
    Group 1 intervention: maximal strength training Group 2 intervention: conventional rehabilitation programme
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary osteoarthritis
  • Unilateral osteoarthritis
  • Age below 65 yrs
  • ASA group 1-2

Exclusion Criteria:

  • Pregnancy
  • Age below 18 yrs
  • Cardiovascular disease
  • Diseases in the musculoskeletal system that could influence on training
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00638417

Locations
Norway
Faculty of Medicine, NTNU
Trondheim, Norway, 7489
Sponsors and Collaborators
Norwegian University of Science and Technology
OrtoMedic A/S, Oslo
Scandinavian Customized Prosthesis (SCP)
Investigators
Principal Investigator: Jan Hoff, Dr. Philos, Professor Faculty of medicine, NTNU, Trondheim, Norway
  More Information

No publications provided

Responsible Party: Professor Jan Hoff, Norwegian university of science and technology
ClinicalTrials.gov Identifier: NCT00638417     History of Changes
Other Study ID Numbers: 4..2005.1527a
Study First Received: March 12, 2008
Last Updated: October 1, 2008
Health Authority: Norway: Norwegian Social Science Data Services

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on June 18, 2013